Farther Finance Advisors’s Myriad Genetics MYGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.3K	Sell	502 -248	-33%	-$1.29K	﹤0.01%	4847
2025 Q4	$4.61K	Sell	750 -2,233	-75%	-$16.2K	﹤0.01%	4355
2025 Q3	$21.6K	Sell	2,983 -2,366	-44%	-$14K	﹤0.01%	2996
2025 Q2	$28.4K	Buy	5,349 +5,264	+6,193%	+$31.1K	﹤0.01%	2453
2025 Q1	$751	Sell	85 -27	-24%	-$324	﹤0.01%	3696
2024 Q4	$1.54K	Sell	112 -89	-44%	-$1.64K	﹤0.01%	3108
2024 Q3	$5.5K	Buy	201 +9	+5%	+$244	﹤0.01%	2599
2024 Q2	$4.6K	Sell	192 -68	-26%	-$1.49K	﹤0.01%	2431
2024 Q1	$5.57K	Buy	260 +226	+665%	+$4.86K	﹤0.01%	2019
2023 Q4	$651	Buy	34 +19	+127%	+$329	﹤0.01%	2884
2023 Q3	$241	Sell	15 -199	-93%	-$3.79K	﹤0.01%	2435
2023 Q2	$4.96K	Hold	214	–	–	﹤0.01%	1437
2023 Q1	$4.97K	Buy	214 +199	+1,327%	+$4.04K	﹤0.01%	1342
2022 Q4	$218	Buy	+15	New	+$279	﹤0.01%	2027